Difference between revisions of "O2k-Publications: Topics"
Line 148: | Line 148: | ||
! MitoPedia | ! MitoPedia | ||
! Number | ! Number | ||
! Comment | |||
|- | |- | ||
|style="text-align:left"|1 | |style="text-align:left"|1 | ||
Line 154: | Line 155: | ||
|style="text-align:left"|[[F-pathway control state]] | |style="text-align:left"|[[F-pathway control state]] | ||
|{{#ask:[[Category:Publications]][[Pathways::F]] |format=count}} | |{{#ask:[[Category:Publications]][[Pathways::F]] |format=count}} | ||
|style="text-align:left"|Fatty acid oxidation, level 5 | |||
|- | |- | ||
|style="text-align:left"|2 | |style="text-align:left"|2 | ||
Line 160: | Line 162: | ||
|style="text-align:left"|[[N-pathway control state]] | |style="text-align:left"|[[N-pathway control state]] | ||
|{{#ask:[[Category:Publications]][[Pathways::N]] |format=count}} | |{{#ask:[[Category:Publications]][[Pathways::N]] |format=count}} | ||
|style="text-align:left"|NADH-linked, level 4 | |||
|- | |- | ||
|style="text-align:left"|3 | |style="text-align:left"|3 | ||
Line 166: | Line 169: | ||
|style="text-align:left"|[[S-pathway control state]] | |style="text-align:left"|[[S-pathway control state]] | ||
|{{#ask:[[Category:Publications]][[Pathways::S]] |format=count}} | |{{#ask:[[Category:Publications]][[Pathways::S]] |format=count}} | ||
|style="text-align:left"|Succinate-linked, level 3 | |||
|- | |- | ||
|style="text-align:left"|4 | |style="text-align:left"|4 | ||
Line 172: | Line 176: | ||
|style="text-align:left"|[[Gp-pathway control state]] | |style="text-align:left"|[[Gp-pathway control state]] | ||
|{{#ask:[[Category:Publications]][[Pathways::Gp]] |format=count}} | |{{#ask:[[Category:Publications]][[Pathways::Gp]] |format=count}} | ||
|style="text-align:left"|Glycerophosphate-linked, level 3 | |||
|- | |- | ||
|style="text-align:left"|5 | |style="text-align:left"|5 | ||
Line 178: | Line 183: | ||
|style="text-align:left"|[[DQ-pathway control state]] | |style="text-align:left"|[[DQ-pathway control state]] | ||
|{{#ask:[[Category:Publications]][[Pathways::DQ]] |format=count}} | |{{#ask:[[Category:Publications]][[Pathways::DQ]] |format=count}} | ||
|style="text-align:left"|Duorquinol-linked, level 2 | |||
|- | |- | ||
|style="text-align:left"|6 | |style="text-align:left"|6 | ||
Line 184: | Line 190: | ||
|style="text-align:left"|[[Complex IV single step]] | |style="text-align:left"|[[Complex IV single step]] | ||
|{{#ask:[[Category:Publications]][[Pathways::CIV]] |format=count}} | |{{#ask:[[Category:Publications]][[Pathways::CIV]] |format=count}} | ||
|style="text-align:left"|Ascorbate & TMPD, level 1 | |||
|- | |- | ||
|style="text-align:left"|7 | |style="text-align:left"|7 | ||
Line 190: | Line 197: | ||
|style="text-align:left"|[[NS-pathway control state]] | |style="text-align:left"|[[NS-pathway control state]] | ||
|{{#ask:[[Category:Publications]][[Pathways::NS]] |format=count}} | |{{#ask:[[Category:Publications]][[Pathways::NS]] |format=count}} | ||
|style="text-align:left"|Convergent CI- and CII-linked electron flow to the [[Q-junction]] | |||
|- | |- | ||
|style="text-align:left"|8 | |style="text-align:left"|8 | ||
Line 196: | Line 204: | ||
|style="text-align:left"|[[Other combinations-pathway control state]] | |style="text-align:left"|[[Other combinations-pathway control state]] | ||
|{{#ask:[[Category:Publications]][[Pathways::Other combinations]] |format=count}} | |{{#ask:[[Category:Publications]][[Pathways::Other combinations]] |format=count}} | ||
|style="text-align:left"| | |||
|- | |- | ||
|style="text-align:left"|9 | |style="text-align:left"|9 | ||
Line 202: | Line 211: | ||
|style="text-align:left"|[[Residual oxygen consumption]] | |style="text-align:left"|[[Residual oxygen consumption]] | ||
|{{#ask:[[Category:Publications]][[Pathways::ROX]] |format=count}} | |{{#ask:[[Category:Publications]][[Pathways::ROX]] |format=count}} | ||
|style="text-align:left"|[[Residual oxygen consumption]] | |||
|- | |- | ||
|} | |} |
Revision as of 14:02, 9 November 2016
O2k-Publications: Topics
- Mitochondria and cell research
O2k-Publications in the MiPMap: MiParea
- mt-Medicine (363 entries)
- Exercise physiology;nutrition;life style •• Comparative MiP;environmental MiP
- Pharmacology;toxicology
- mt-Biogenesis;mt-density •• Genetic knockout;overexpression
- Instruments;methods
Pathological states
- Alphabetical order
•• Aging;senescence •• Alzheimer's •• Autism •• Cancer •• Cardiovascular •• COPD •• Diabetes •• Inherited •• Infectious •• Myopathy •• Neurodegenerative •• Obesity •• Parkinson's •• Sepsis
Stress conditions
- Alphabetical order
•• Cell death •• Cryopreservation •• Hypoxia •• Ischemia-reperfusion injury and preservation •• Mitochondrial disease;degenerative disease and defect •• Oxidative stress;RONS •• Permeability transition •• Temperature: hypothermia; hyperthermia
Organisms
- Mammals and models
- Human •• Pig •• Horse •• Bovines •• Cat •• Dog •• Rabbit •• Mouse •• Rat •• Guinea pig•• Other mammals
- Chicken •• Zebrafish •• Drosophila •• Caenorhabditis elegans •• Artemia •• Saccharomyces cerevisiae
- Comparative MiP
- Non-mammals
- O2k-Publications: Organisms
- Amphibians •• Annelids •• Birds •• Crustaceans •• Eubacteria •• Fishes •• Fungi •• Hexapods •• Molluscs •• Nematodes •• Other invertebrates •• Plants •• Protists •• Reptiles
Tissues and cells
- Tissues - alphabetical order
•• Fat •• Genital •• Heart •• Kidney •• Liver •• Lung;Gill •• Nervous system •• Skeletal muscle
- Cell types - alphabetical order
•• Blood cells •• Endothelial;epithelial;mesothelial cell •• Fibroblast •• Islet cell;pancreas;thymus •• Lymphocyte •• Platelet •• Stem cells
- Cell lines - alphabetical order
•• CHO •• HEK •• HeLa •• Neuroblastoma •• HUVEC •• Macrophage-derived cell lines
Preparations
- Intact organism •• Intact organ •• Intact cells •• Permeabilized cells •• Permeabilized tissue •• Homogenate •• Isolated mitochondria •• SMP •• Chloroplasts •• Enzyme •• Oxidase and biochemical oxidation
Enzymes
- Alphabetical order
•• Adenine nucleotide translocase •• Complex I •• Complex II;succinate dehydrogenase •• Complex III •• Complex IV;cytochrome c oxidase •• Complex V;ATP synthase •• Inner mt-membrane transporter •• Marker enzyme •• Supercomplex •• TCA cycle and matrix dehydrogenases •• Uncoupling protein
Regulation
- Alphabetical order
•• ADP •• ATP production •• Aerobic glycolysis •• Amino acid •• Calcium •• Coupling efficiency;uncoupling •• Cyt c •• Fatty acid •• Flux control •• Inhibitor •• Ion;substrate transport •• mt-Membrane potential •• Oxygen kinetics •• Q-junction effect •• Redox state •• Substrate •• Temperature •• Threshold;excess capacity •• Uncoupler
Coupling control states
•• OXPHOS •• ROUTINE •• ETS •• LEAK
Pathway control states
# O2k-Publications Number MitoPedia Number Comment 1 F 608 F-pathway control state 752 Fatty acid oxidation, level 5 2 N 2473 N-pathway control state 2621 NADH-linked, level 4 3 S 1684 S-pathway control state 1792 Succinate-linked, level 3 4 Gp 157 Gp-pathway control state 183 Glycerophosphate-linked, level 3 5 DQ 26 DQ-pathway control state 31 Duorquinol-linked, level 2 6 CIV 702 Complex IV single step 730 Ascorbate & TMPD, level 1 7 NS 1579 NS-pathway control state 1636 Convergent CI- and CII-linked electron flow to the Q-junction 8 Other combinations 132 Other combinations-pathway control state 148 9 ROX 1519 Residual oxygen consumption 1571 Residual oxygen consumption
MiPMap combinations - examples
- Examples for specific combinations
- O2k-Publications: Human skeletal muscle •• O2k-Publications: Human heart •• O2k-Publications: Skeletal muscle - human vs mouse
- Browse data